{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-021923","form_type":"8-K","ticker":"ETST","cik":"0001538495","company_name":"Earth Science Tech, Inc.","filed_at":"2023-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.321635+00:00","generated_at":"2026-06-13T19:58:23.354203+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"ETST retired ~$1.5M (81%) of liabilities, expanded pharmacy licenses, eliminated convertible notes","bullets":["Retired ~$1.5M or 81% of liabilities from start of FY2022.","RxCompound obtained dispensing licenses in 7 additional states; sterile compounding lab began sales May 2023.","Largest shareholder converted $385K in notes to equity; no convertible notes remain outstanding.","Created DocProtocol.com, viagramia.com, and mysexgummy.com for telehealth and men's health.","CEO expects significant revenue growth; believes no further financing needed unless for an acquisition."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-021923","json":"https://secwatch.observer/filing/0001493152-23-021923.json","markdown":"https://secwatch.observer/filing/0001493152-23-021923.md","text":"https://secwatch.observer/filing/0001493152-23-021923.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1538495/000149315223021923/0001493152-23-021923-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1538495/000149315223021923/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T19:58:23.354203+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}